Bax mRNA therapy using cationic liposomes for human malignant melanoma

Journal of Gene Medicine

Volumn 10, Issue 8, 2008, Pages 910-917

  Okumura, Kenya ^a,b   Nakase, Minoru ^a   Inui, Madoka ^a   Nakamura, Shinnosuke ^c   Watanabe, Yoshihiro ^a   Tagawa, Toshiro ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

^c Department of Dentistry and Oral Surgery   (Japan)

Author keywords

Bax; Cationic liposome; Gene therapy; Malignant melanoma; mRNA

Indexed keywords

CASPASE 3; LIPOFECTIN; LIPOSOME; MESSENGER RNA; PLASMID DNA; PROTEIN BAX; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; ENZYME ACTIVITY; FEMALE; GENE TRANSFER; GROWTH INHIBITION; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; MELANOMA; MELANOMA CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; GENE THERAPY; HUMANS; LIPOSOMES; MELANOMA; RNA, MESSENGER;

MUS; MUS MUSCULUS;

EID: 49349099122     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1214     Document Type: Article

References (39)

1. Marzo I, Brenner C, Zamzami N, et al. Bax and adenine nudeotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-2031.
2. Shimizu S, Narita M, Tsuzimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399: 483-487.
3. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
4. Coll JL, Neogoescu A, Louis N, et al. Antitumor activity of Bax and p. 53 naked gene transfer in lung cancer: in vitro and in vivo analysis. Hum Gene Ther 1998; 9: 2063-2074.
5. Huh WK, Gomez-Navarro J, Arafat WO, et al. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix. Gynecol Oncol 2001; 83: 370-377.
6. Li X, Marani M, Yu J, et al. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res 2001; 61: 186-91.
7. Kobayashi T, Sawa H, Sawa H, et al. Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation. Int J Oncol 2002; 20: 723-728.
8. Pirocanac EC, Nassirpour R, Yang M, et al. Bax-induction gene therapy of pancreatic cancer. J Surg Res 2002; 106: 346-351.
9. Tumemitu Y, Kagawa S, Tokunaga N, et al. Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer. Gut 2004; 53: 554-560.
10. Okumura K Nakase M, Nakamura S, Inui M, Hiramoto K, Tagawa T. Antitumor activity of cationic liposome-mediated Bax gene transfer in osteosarcoma cells: induction of apoptosis and caspase-independent cell death. Int J Oncol 2005; 27: 433-438.
11. Okumura K, Nakase M, Nakamura S, Kamei T, Inui M, Tagawa T. Bax gene therapy for human osteosarcoma using cationic liposomes in vivo. Oncol Rep 2007; 17: 769-773.
12. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-2245.
13. Boyce N. Trial halted after gene shows up in semen. Nature 2001; 414: 677.
14. Check E. A tragic setback. Nature 2002; 420: 116-118.
15. Yanagihara K, Cheng PW. Lectin enhancement of the lipofection efficiency in human lung carcinoma cells. Biochim Biophys Acta 1999; 1472: 25-33.
16. Yanagihara K, Cheng H, Cheng PW. Effects of epidermal growth factor, transferrin, and insulin on lipofection efficiency in human lung carcinoma cells. Cancer Gene Ther 2000; 7: 59-65.
17. Nakase M, Inui M, Okumura K, et al. p53 gene therapy of human osteosarcoma using a transferring-modified cationic liposome. Mol Cancer Ther 2005; 4: 625-631.
18. Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 1989; 86: 6077-6081.
19. Khaleghpour K, Kahvejian A, Crescenzo G, et al. Dual interactions of the translational repressor paip2 with poly(A) binding protein. Mol Cell Biol 2001; 21: 5200-5213.
20. Bettinger T, Carlisle RC, Read ML, Ogris M, Seymour LW. Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res 2001; 29: 3882-3891.
21. Stepinski J, Waddell C, Stolarski R, et al. Synthesis and properties of mRNAs; containing the novel 'anti-reverse' cap analogs 7-methyl (3'-O-methyl) GpppG and 7-methyl (3'-deoxy) GpppG. RNA 2001; 7: 1486-1495.
22. Mockey M, Gonçalves C, Dupuy FP, et al. mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with poly(A) chains in cis and in trans for a high protein expression level. Biochem Biophys Res Commun 2006; 340: 1062-1068.
23. Hess PR, Boczkowski D, Nair SK, et al. Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Cancer Irnmunol Immunother 2006; 55: 672-683.
24. Mockey M, Bourseau. E, Chandrashekhar V, et al. mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes. Cancer Gene Ther 2007; 14: 802-814.
25. Tagawa T, Yatani R, Nishioka H, Murata M. Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line. Int J Oral Surg 1981; 10(Suppl 1): 16-20.
26. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans; CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-413.
27. Ryuke Y, Mizuno M, Natsume A, et al. Growth inhibition of subcutaneous mouse melanoma and induction of natural killer cells by liposome-mediated interferon-β gene therapy. Melanoma Res 2003; 13: 349-356.
28. Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-129.
29. Dwarki VJ, Malone RW, Venna IM. Cationic liposome-mediated RNA transfection. Methods Enzymol 1993; 217: 644-654.
30. Lu D, Benjamin R, Kim M, et al. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther 1994; 1: 245-252.
31. Oltvai ZN, Milliman CL Korsmeyer J. Bel-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
32. Wagener C, Bargou RC, Daniel PT, et al. Induction of the death-promoting gene Bax-α sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 1996; 67: 138-141.
33. Guo B, Yin M, Tǒth K, Cao S, Azrak RG, Rusturn YM. Dimerization of mitochondrial Bax is associated with increased drug response in Bax-transfected A253 cells. Oncol Res 1999; 11: 91-99.
34. Yanqiu Z, Bing X, Baofun C, Taidong Q, Daiming F. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by Bax gene transduction. Chin Med J 2000; 113: 977-980.
35. Kobayashi T, Sawa H, Morikawa J, Zhang W, Shiku H. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Jpn J Cancer Res 2000; 91: 1264-1268.
36. Sakakura C, Sweeney EA, Shirahama T, et al. Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 1996; 67: 101-105.
37. Arafat WO, Gǒmez-Navarro J, Mang J, et al. An adenovirus encoding pro-apoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Mol Ther 2000; 1: 545-554.
38. Arafat WO, Buchsbaum DJ, Gómez-Navarro J, et al. An adenovirus encoding pro-apoptotic Bax synergistically radiosensitizes malignant glioma. Int J Radiat Oncol Biol Phys 2003; 55: 1037-1050.
39. Kim R, Inoue H, Toge T. Bax is an important determinant for radiatioh sensitivity in esophageal carcinoma cells. Int J Mol Med 2004; 14: 697-706.